We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS Urges Cautious Approach to Moving Medicare Part B Drugs to Rx Benefit
HHS Urges Cautious Approach to Moving Medicare Part B Drugs to Rx Benefit
March 30, 2005
Although shifting some Medicare Part B drugs to Part D could stoke competitive pressures on pharmaceutical pricing, the HHS does not recommend consolidating the coverage until the Medicare prescription drug benefit has had a chance to get up and running, according to a new report.